| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/17/2000 | WO2000047049A1 Method for reducing hip joint laxity |
| 08/17/2000 | WO2000033887A3 Methods and formulations for reducing circulating antibodies |
| 08/17/2000 | WO2000033870A3 New cancer treatments |
| 08/17/2000 | WO2000021574A3 Site-directed dual pegylation of proteins |
| 08/17/2000 | WO2000016752A9 Transdermal devices comprising essential oils for aromatherapy |
| 08/17/2000 | WO2000007627A3 Topical delivery systems for active agents |
| 08/17/2000 | DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene |
| 08/17/2000 | DE19906368A1 Emulgatoren Emulsifiers |
| 08/17/2000 | DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope |
| 08/17/2000 | DE19905906A1 Flexible, water-soluble or water-dispersible coating agent, binder or film former for pharmaceutical formulations, comprises new or known vinyl ester-polyether graft copolymer, |
| 08/17/2000 | DE19905801A1 Verfahren zur Herstellung folienförmiger Darreichungsformen Process for producing film-like administration forms |
| 08/17/2000 | DE19905639A1 Wasserlösliche oder wasserquellbare Polymerisate Water-soluble or water-swellable polymers |
| 08/17/2000 | CA2362561A1 Prolonged release bioadhesive vaginal gel dosage form |
| 08/17/2000 | CA2362523A1 Nitroreductase enzymes |
| 08/17/2000 | CA2362464A1 A synthetic peptide disturbing intracellular signaling |
| 08/17/2000 | CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor |
| 08/17/2000 | CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules |
| 08/17/2000 | CA2361569A1 Injectable collagen-based system for delivery of cells or therapeutic agents |
| 08/17/2000 | CA2359886A1 Polynucleotide compositions for intramuscular and intradermal administration |
| 08/17/2000 | CA2359706A1 Freeze-dried agent containing paramylon, production and utilization thereof |
| 08/17/2000 | CA2298764A1 Pharmaceutical filled hard capsules |
| 08/16/2000 | EP1028137A2 Polymeric matrices and their uses in pharmaceutical compositions |
| 08/16/2000 | EP1028129A1 Water-soluble or water-swellable polymers |
| 08/16/2000 | EP1027921A1 Stable emulsion, method for producing it and the emulsifier |
| 08/16/2000 | EP1027895A2 Erysipelothrix rhusiopathiae antigens and vaccine compositions |
| 08/16/2000 | EP1027893A2 Alginate containing medicament and implant for treating fibrosis |
| 08/16/2000 | EP1027888A2 Osmotic system for delivery of solid amorphous dispersions of drugs |
| 08/16/2000 | EP1027887A2 Matrix controlled release device |
| 08/16/2000 | EP1027886A2 Pharmaceutical solid dispersions |
| 08/16/2000 | EP1027885A2 Basic drug compositions with enhanced bioavailability |
| 08/16/2000 | EP1027413A1 Fractionated vegetable oil |
| 08/16/2000 | EP1027073A2 Enhanced effects for hapten conjugated therapeutics |
| 08/16/2000 | EP1027072A1 Controlled release compositions comprising gellan gum gels |
| 08/16/2000 | EP1027070A1 Conjugate heat shock protein-binding peptides |
| 08/16/2000 | EP1027065A1 Method for destroying retinal pigment epithelial cells |
| 08/16/2000 | EP1027061A1 Imine-forming polysaccharides, preparation thereof and the use thereof as adjuvants and immunostimulants |
| 08/16/2000 | EP1027049A1 Intranasal formulation containing scopolamine and method of treating motion sickness |
| 08/16/2000 | EP1027038A1 Taste masked pharmaceutical compositions |
| 08/16/2000 | EP1027037A1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient |
| 08/16/2000 | EP1027036A2 Taste masked formulations |
| 08/16/2000 | EP1027035A2 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these |
| 08/16/2000 | EP1027033A2 High efficiency encapsulation of charged therapeutic agents in lipid vesicles |
| 08/16/2000 | EP1026947A1 Composition and method for treating penile erectile dysfunction |
| 08/16/2000 | EP1026945A1 Improved iodine antimicrobial compositions containing nonionic surfactants and halogen anions |
| 08/16/2000 | EP1011609A4 Compositions for cosmetic applications |
| 08/16/2000 | EP0768896B1 Low-dose steroid tablets containing gallic acid esters as antioxidant agent, process for the manufacture of said tablets, and uses of said tablets |
| 08/16/2000 | EP0722470B1 Multifunctional organic polymers |
| 08/16/2000 | EP0667166B1 1-alpha,24-(oh)2-vitamin d3 emulsion composition |
| 08/16/2000 | CN1263533A New formulation |
| 08/16/2000 | CN1263473A Composition and method for enhancing transport across biological membranes |
| 08/16/2000 | CN1263472A Sustained-release delayed gels |
| 08/16/2000 | CN1263470A Immunopotentiating composition |
| 08/16/2000 | CN1263469A Pharmaceutical compositions of peptides having low solubility in physiological medium |
| 08/16/2000 | CN1263466A Solutions containing azasteroids |
| 08/16/2000 | CN1263461A Pharmaceutical composition |
| 08/16/2000 | CN1262927A Dihydroartemisinin preparation for controlling broad-spectrum malaria and its preparation method |
| 08/16/2000 | CN1055417C Nucleus-shell structure protein high-molecule microball and its manufacturing method |
| 08/16/2000 | CN1055414C Method for preparation of polymeric gas or air filled microballoons |
| 08/16/2000 | CN1055413C Method for preparing composition suitable for injecting into vivo-blood vessel and body cavity |
| 08/15/2000 | US6103881 GnRH analogs for destroying gonadotrophs |
| 08/15/2000 | US6103820 Free radical copolymerization in water solution containing n-vinyllactam, an alcohol and an initiator, metered in to the reaction vessel |
| 08/15/2000 | US6103771 Method of treating neuroma pain |
| 08/15/2000 | US6103770 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds |
| 08/15/2000 | US6103757 Administering a benzofuran derivative to the human suffering from arrhythmia |
| 08/15/2000 | US6103746 Methods and compositions for the protection of mitochondria |
| 08/15/2000 | US6103704 Topically administering a therapeutically effective dosage of a formulation which comprises hyaluronic acid and an antiinflammatory or anticarcinogenic agent; treatment of diseases and conditions of the skin and exposed tissue |
| 08/15/2000 | US6103275 Systems and methods for topical treatment with nitric oxide |
| 08/15/2000 | US6103274 Pharmaceutical, orally applicable composition |
| 08/15/2000 | US6103267 Dispersion comprising non-aqueous phase containing particles comprising water soluble or dispersible polymer, non-polymeric water soluble or dispersible ascorbic acid material, water, surfactant with low hydrophilic-lipophilic balance |
| 08/15/2000 | US6103262 Composition capable of delivering acceptable bioavailability for up to twenty-four hours |
| 08/15/2000 | US6103261 Opioid formulations having extended controlled release |
| 08/15/2000 | US6103260 Antifoam oral solid dosage form preparations |
| 08/15/2000 | US6103247 Composition containing a non-photocatalytic metal oxide and tocopherol, its use in the cosmetics and/or dermatological field and processes employing it |
| 08/15/2000 | US6103243 Oral vaccines |
| 08/15/2000 | US6103236 In which a compound having an affinity for a target cell is bound to a toxin through a spacer consisting essentially of polyalkylene glycol and a dipeptide. |
| 08/15/2000 | US6103235 Exposing the recipient to an anti-cd3-dt immunotoxin with reduced anti-dt antibody binding so as to reduce the recipients t-cell lymphocyte population by at lest 80% in the presence or absence of anti-dt antibodies in the recipient |
| 08/15/2000 | US6103234 Antibody to an inflammatory cytokine, said inflammatory cytokine comprising a mature macrophage inflammatory protein -2 (mmip-2) |
| 08/15/2000 | US6103233 Cellular and serum protein anchors and conjugates |
| 08/15/2000 | US6103219 Pharmaceutical excipient having improved compressibility |
| 08/15/2000 | US6103216 Hepatocyte-selective oil-in-water emulsion |
| 08/15/2000 | US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof |
| 08/15/2000 | CA2287056C Orally administrable solid ribavirin dosage forms and process for making them |
| 08/15/2000 | CA2153391C Inducing cytotoxic t lymphocyte responses |
| 08/15/2000 | CA1341087C Medicaments including hyaluronic acid as a drug delivery system |
| 08/10/2000 | WO2000046384A1 Nucleic acid uptake and release vehicle |
| 08/10/2000 | WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 08/10/2000 | WO2000046182A1 Method of preparing alkylated salicylamides |
| 08/10/2000 | WO2000045878A2 Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor |
| 08/10/2000 | WO2000045868A1 Thermo-reversible polymer for intralumenal implant |
| 08/10/2000 | WO2000045855A2 Diagnostic imaging of lymph structures |
| 08/10/2000 | WO2000045850A2 Drug delivery vehicle |
| 08/10/2000 | WO2000045849A2 Use of cationic lipids to generate anti-tumor immunity |
| 08/10/2000 | WO2000045848A1 Pharmaceutical composition of hydrophobically modified hedgehog proteins and their use |
| 08/10/2000 | WO2000045847A1 Novel mucosal delivery system |
| 08/10/2000 | WO2000045845A2 Liposome composition and method for administration of a radiosensitizer |
| 08/10/2000 | WO2000045841A2 Human papilloma virus vaccine formulations |
| 08/10/2000 | WO2000045835A1 Vascular endothelial growth factor-2 |
| 08/10/2000 | WO2000045822A1 Phosphocholine surfactants and their use |
| 08/10/2000 | WO2000045814A1 Methods and compositions to enhance white blood cell count |
| 08/10/2000 | WO2000045796A1 Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery |